217 related articles for article (PubMed ID: 24278309)
1. Acetate supplementation induces growth arrest of NG2/PDGFRα-positive oligodendroglioma-derived tumor-initiating cells.
Long PM; Tighe SW; Driscoll HE; Moffett JR; Namboodiri AM; Viapiano MS; Lawler SE; Jaworski DM
PLoS One; 2013; 8(11):e80714. PubMed ID: 24278309
[TBL] [Abstract][Full Text] [Related]
2. Triacetin-based acetate supplementation as a chemotherapeutic adjuvant therapy in glioma.
Tsen AR; Long PM; Driscoll HE; Davies MT; Teasdale BA; Penar PL; Pendlebury WW; Spees JL; Lawler SE; Viapiano MS; Jaworski DM
Int J Cancer; 2014 Mar; 134(6):1300-10. PubMed ID: 23996800
[TBL] [Abstract][Full Text] [Related]
3. Acetate supplementation as a means of inducing glioblastoma stem-like cell growth arrest.
Long PM; Tighe SW; Driscoll HE; Fortner KA; Viapiano MS; Jaworski DM
J Cell Physiol; 2015 Aug; 230(8):1929-43. PubMed ID: 25573156
[TBL] [Abstract][Full Text] [Related]
4. N-acetylaspartate (NAA) and N-acetylaspartylglutamate (NAAG) promote growth and inhibit differentiation of glioma stem-like cells.
Long PM; Moffett JR; Namboodiri AMA; Viapiano MS; Lawler SE; Jaworski DM
J Biol Chem; 2013 Sep; 288(36):26188-26200. PubMed ID: 23884408
[TBL] [Abstract][Full Text] [Related]
5. Acetate supplementation restores chromatin accessibility and promotes tumor cell differentiation under hypoxia.
Li Y; Gruber JJ; Litzenburger UM; Zhou Y; Miao YR; LaGory EL; Li AM; Hu Z; Yip M; Hart LS; Maris JM; Chang HY; Giaccia AJ; Ye J
Cell Death Dis; 2020 Feb; 11(2):102. PubMed ID: 32029721
[TBL] [Abstract][Full Text] [Related]
6. Metabolic acetate therapy improves phenotype in the tremor rat model of Canavan disease.
Arun P; Madhavarao CN; Moffett JR; Hamilton K; Grunberg NE; Ariyannur PS; Gahl WA; Anikster Y; Mog S; Hallows WC; Denu JM; Namboodiri AM
J Inherit Metab Dis; 2010 Jun; 33(3):195-210. PubMed ID: 20464498
[TBL] [Abstract][Full Text] [Related]
7. Oral acetate supplementation attenuates N-methyl D-aspartate receptor hypofunction-induced behavioral phenotypes accompanied by restoration of acetyl-histone homeostasis.
Singh S; Choudhury A; Gusain P; Parvez S; Palit G; Shukla S; Ganguly S
Psychopharmacology (Berl); 2016 Apr; 233(7):1257-68. PubMed ID: 26832338
[TBL] [Abstract][Full Text] [Related]
8. Progress toward acetate supplementation therapy for Canavan disease: glyceryl triacetate administration increases acetate, but not N-acetylaspartate, levels in brain.
Mathew R; Arun P; Madhavarao CN; Moffett JR; Namboodiri MA
J Pharmacol Exp Ther; 2005 Oct; 315(1):297-303. PubMed ID: 16002461
[TBL] [Abstract][Full Text] [Related]
9. Extensive aspartoacylase expression in the rat central nervous system.
Moffett JR; Arun P; Ariyannur PS; Garbern JY; Jacobowitz DM; Namboodiri AM
Glia; 2011 Oct; 59(10):1414-34. PubMed ID: 21598311
[TBL] [Abstract][Full Text] [Related]
10. Asymmetry-defective oligodendrocyte progenitors are glioma precursors.
Sugiarto S; Persson AI; Munoz EG; Waldhuber M; Lamagna C; Andor N; Hanecker P; Ayers-Ringler J; Phillips J; Siu J; Lim DA; Vandenberg S; Stallcup W; Berger MS; Bergers G; Weiss WA; Petritsch C
Cancer Cell; 2011 Sep; 20(3):328-40. PubMed ID: 21907924
[TBL] [Abstract][Full Text] [Related]
11. Valproic acid induces the glutamate transporter excitatory amino acid transporter-3 in human oligodendroglioma cells.
Bianchi MG; Franchi-Gazzola R; Reia L; Allegri M; Uggeri J; Chiu M; Sala R; Bussolati O
Neuroscience; 2012 Dec; 227():260-70. PubMed ID: 23041758
[TBL] [Abstract][Full Text] [Related]
12. Modulation of the Wnt/beta-catenin pathway in human oligodendroglioma cells by Sox17 regulates proliferation and differentiation.
Chen HL; Chew LJ; Packer RJ; Gallo V
Cancer Lett; 2013 Jul; 335(2):361-71. PubMed ID: 23474492
[TBL] [Abstract][Full Text] [Related]
13. NG2-expressing glial precursor cells are a new potential oligodendroglioma cell initiating population in N-ethyl-N-nitrosourea-induced gliomagenesis.
Briançon-Marjollet A; Balenci L; Fernandez M; Estève F; Honnorat J; Farion R; Beaumont M; Barbier E; Rémy C; Baudier J
Carcinogenesis; 2010 Oct; 31(10):1718-25. PubMed ID: 20651032
[TBL] [Abstract][Full Text] [Related]
14. miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells.
Silber J; Lim DA; Petritsch C; Persson AI; Maunakea AK; Yu M; Vandenberg SR; Ginzinger DG; James CD; Costello JF; Bergers G; Weiss WA; Alvarez-Buylla A; Hodgson JG
BMC Med; 2008 Jun; 6():14. PubMed ID: 18577219
[TBL] [Abstract][Full Text] [Related]
15. N-Acetylaspartate Synthase Deficiency Corrects the Myelin Phenotype in a Canavan Disease Mouse Model But Does Not Affect Survival Time.
Maier H; Wang-Eckhardt L; Hartmann D; Gieselmann V; Eckhardt M
J Neurosci; 2015 Oct; 35(43):14501-16. PubMed ID: 26511242
[TBL] [Abstract][Full Text] [Related]
16. Acetate supplementation attenuates lipopolysaccharide-induced neuroinflammation.
Reisenauer CJ; Bhatt DP; Mitteness DJ; Slanczka ER; Gienger HM; Watt JA; Rosenberger TA
J Neurochem; 2011 Apr; 117(2):264-74. PubMed ID: 21272004
[TBL] [Abstract][Full Text] [Related]
17. Acetate supplementation modulates brain histone acetylation and decreases interleukin-1β expression in a rat model of neuroinflammation.
Soliman ML; Smith MD; Houdek HM; Rosenberger TA
J Neuroinflammation; 2012 Mar; 9():51. PubMed ID: 22413888
[TBL] [Abstract][Full Text] [Related]
18. Cell-Based Therapy for Canavan Disease Using Human iPSC-Derived NPCs and OPCs.
Feng L; Chao J; Tian E; Li L; Ye P; Zhang M; Chen X; Cui Q; Sun G; Zhou T; Felix G; Qin Y; Li W; Meza ED; Klein J; Ghoda L; Hu W; Luo Y; Dang W; Hsu D; Gold J; Goldman SA; Matalon R; Shi Y
Adv Sci (Weinh); 2020 Dec; 7(23):2002155. PubMed ID: 33304759
[TBL] [Abstract][Full Text] [Related]
19. Long-term temozolomide treatment induces marked amino metabolism modifications and an increase in TMZ sensitivity in Hs683 oligodendroglioma cells.
Lamoral-Theys D; Le Mercier M; Le Calvé B; Rynkowski MA; Bruyère C; Decaestecker C; Haibe-Kains B; Bontempi G; Dubois J; Lefranc F; Kiss R
Neoplasia; 2010 Jan; 12(1):69-79. PubMed ID: 20072655
[TBL] [Abstract][Full Text] [Related]
20. [Common mechanism underlying oligodendrocyte development and oligodendrogliomagenesis].
Kondo T
Brain Nerve; 2009 Jul; 61(7):741-51. PubMed ID: 19618851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
